SCHEMBL1664061

SCHEMBL1664061

O=C(c1ccc(NC(=O)c2cccc3[nH]ccc23)cc1)c1ccc(Nc2ccc(N3CCC(O)CC3)cc2)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DHPS P49366 1/20 0.50
GOT1 P17174 4/20 0.48
KMT2A Q03164 4/20 0.43
MEN1 O00255 3/20 0.43
RAB9A P51151 6/20 0.42
NPC1 O15118 5/20 0.42
GFER P55789 1/20 0.42
KDR P35968 3/20 0.42
ALDH1A1 P00352 4/20 0.41
MAPT P10636 4/20 0.40
SMN1; SMN2 Q16637 3/20 0.40
TP53 P04637 1/20 0.40
MCL1 Q07820 1/20 0.40
GAA P10253 2/20 0.40
MAPK1 P28482 2/20 0.40
TDP1 Q9NUW8 2/20 0.40
L3MBTL1 Q9Y468 2/20 0.40
NPSR1 Q6W5P4 1/20 0.40
LMNA P02545 1/20 0.40
ATM Q13315 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8770716 0.95 DHPS (0.53) DHPSGOT1KMT2AMEN1RAB9A
SCHEMBL1664323 0.87 HRH3 (0.51) KMT2AMEN1RAB9ANPC1GFER
SCHEMBL1667308 0.85 GRM5 (0.46) KMT2AMEN1RAB9ANPC1GFER
SCHEMBL1664064 0.83 RAB9A (0.40) KMT2AMEN1RAB9ANPC1GFER
SCHEMBL1664936 0.82 HRH3 (0.52) RAB9ANPC1GFERALDH1A1MAPT
SCHEMBL8770073 0.82 HRH3 (0.52) RAB9ANPC1GFERALDH1A1MAPT
SCHEMBL1664934 0.82 HRH3 (0.55) KMT2AMEN1RAB9ANPC1GFER
SCHEMBL1664961 0.81 NPC1 (0.65) KMT2AMEN1RAB9ANPC1GFER
SCHEMBL1667309 0.80 RAB9A (0.41) KMT2AMEN1RAB9ANPC1GFER
SCHEMBL8771583 0.80 RAB9A (0.47) KMT2AMEN1RAB9ANPC1GFER

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2642994-A2 USE OF HEMATOPOIETIC GROWTH FACTOR MIMETICS Ligand Pharmaceuticals Incorporated (US) 2013-10-02 EP disclosed
EP-2488486-A1 HEMATOPOIETIC GROWTH FACTOR MIMETIC SMALL MOLECULE COMPOUNDS AND THEIR USES Ligand Pharmaceuticals Inc. (US) 2012-08-22 EP disclosed
WO-2012068406-A2 USE OF HEMATOPOIETIC GROWTH FACTOR MIMETICS LIGAND PHARMACEUTICALS INCORPORATED (US) 2012-05-24 WO disclosed
WO-2011046954-A1 HEMATOPOIETIC GROWTH FACTOR MIMETIC SMALL MOLECULE COMPOUNDS AND THEIR USES LIGAND PHARMACEUTICALS INC. (US) 2011-04-21 WO disclosed